Lokacin da Takardu ke Magana Vectors Vendor: Yadda Ake Karanta Bayanan Reagent (Nazarin Harka: GenScript pcDNA3 a cikin Binciken MDM2)
Lokacin da manyan masu bincike da manyan masana kimiyya masu bincike ke bincika sabbin wallafe-wallafen a cikin ilimin halitta ko ilimin halitta, Ana yawan ɗaukar ambaton masu siyarwa azaman tambarin amincewa da ba a fayyace ba. Ganin wani nau'in furuci na dabbobi masu shayarwa ko kuma peptide na al'ada da aka ambata a cikin takardu ashirin da aka bita ya haifar da zato na dogaro.. Idan dakunan gwaje-gwaje masu zaman kansu da yawa akai-akai suna samun takamaiman kayan aikin GenScript pcDNA3 ko peptide na roba na kasuwanci don nazarin siginar MDM2-p53, yana da kyau a ba da oda daidai lambar kasida ɗaya kuma a ci gaba kai tsaye zuwa aiwatar da benci.
Duk da haka, kula da ambaton dillalai a matsayin wakili don ingancin batch na ƙwaƙƙwara shine ɗayan mafi yawan abubuwan da ke haifar da bayanan dakin gwaje-gwaje da ba za a iya misaltawa ba.. Abubuwan da aka ambata a cikin mujallolin da aka yi bita na tsara sun rubuta tarihin amfani, ba takamaiman na zahiri ba, sinadaran, ko tabbaci na aiki. Kasusuwan plasmid na kasuwanci suna fuskantar bita-bita na jerin masu siyarwa, wucewa a cikin nau'ikan masaukin baki yana gabatar da ƙananan bambance-bambancen ƙananan jama'a, da maganganun maganganu da masu tallata hoto za su iya yin halin rashin tabbas dangane da asalin kwayar halitta ta salula.
Kiyaye sake fasalin gwaji yana buƙatar koyon yadda ake karanta labaran wallafe-wallafe da mahimmanci da aiwatar da mai zaman kansa., orthogonal ingancin iko (QC) yarjejeniya kafin ɗaukar duk wani reagent da aka yi amfani da wallafe-wallafe.
Bayanan Kasuwanci na Kasuwanci vs. Tallafin taron: Rusa Siginonin Amincewa da Kai Kai tsaye
Don kimanta abubuwan da aka samo wallafe-wallafe yadda ya kamata, dakunan gwaje-gwaje dole ne su bambanta tsakanin siginar kasuwanci daban-daban. A cikin wallafe-wallafen kimiyya, mai sayarwa ya ambaci, bayanan bayanai, kuma abubuwan tallafawa taron suna yin ayyuka daban-daban na gudanarwa da haɓakawa, amma babu ɗayansu da ke da tabbacin cewa sabon yawa daga mai siyar da kasuwanci zai yi daidai a cikin binciken ku.
Ambaton Adabi / RRID → Rikodin Amfani na Tarihi (Inda aka sayo)
Tallafin Mai Talla → Siginar Talla ta Kasuwanci (Alamar gani)
Orthogonal QC & CoA → Tabbataccen Hujja (Ƙimar takamaiman ainihi & tsarki)
Nassosin Adabi da Masu Gano Mabuɗin Bincike (RRIDs)
Lokacin da takarda ta jera lambar katalogi ko Mai Gano Albarkatun Bincike (INA SON), yana tabbatar da gano bayanan da aka buga. Madaidaitan ayyukan ƙididdiga suna haɓaka tabbatarwa da haɓakawa na zahiri ta hanyar ƙyale masu karatu su bi diddigin albarkatu a cikin karatun., kamar yadda aka nuna a cikin Jagorar ɗaba'ar NIH akan tabbatarwa da ambaton bayanai.
Rubutun ma'adinan rubutu kamar CiteAb sun tattara waɗannan ƙididdiga don auna ɗaukar kasuwa da yanayin amfani, samar da haske mai mahimmanci game da kasancewar mai siyarwa, kamar yadda aka zayyana a ciki CiteAb's nazarin ambaton samfurin kimiyyar rayuwa. Yana ambaton ainihin lambobi kasida na samfur, lambobi masu yawa, da RRIDs suna tabbatar da cewa takwarorinsu na kimiyya zasu iya gano abubuwan da ke cikin tushe, kamar yadda aka bayyana a cikin Jagorar StressMarq akan ambaton samfur na RRID.
Duk da haka, Rubutun wallafe-wallafen ya rubuta abin da ƙungiyar binciken da ta gabata ta saya-ba ta tabbatar da cewa an inganta reagent da kansa ba kafin a buga gwajin su..
Key Takeaway: Ƙididdigar da aka yi bita na tsara ta tabbatar da cewa an yi amfani da takamaiman albarkatun mai siyarwa a cikin binciken da aka buga, amma baya maye gurbin na musamman na zahiri, jeri, ko tabbaci na aiki a cikin ɗakin binciken ku.
Tallafin Abubuwan Kasuwanci da Ganuwa Alamar
Tallafin taron—kamar rumfunan tallace-tallace a mahimman tarukan tarukan, ƙwararrun tarurrukan fasaha, ko tallafin tafiye-tafiye na kimiyya-aiki kawai azaman alamun gani na kasuwanci. Tallafi yana nuna ƙarfin tallan mai siyarwa, ba analytical tsarki ko aikin aminci na su nazarin halittu reagents.
Dogaro da shaharar tambarin mai siyarwa ko yawan ambaton wallafe-wallafe a matsayin madadin kula da ingancin ciki yana haifar da haɗarin ilimin halitta., musamman a cikin mahimman hanyoyin sarrafawa kamar siginar MDM2/p53.
Nazarin Harka: GenScript pcDNA3 Magana yana Gina a cikin Binciken Siginar MDM2/p53
Don fahimtar yadda wallafe-wallafen da aka ambata na iya gabatar da bambancin gwaji, yi la'akari da yin amfani da GenScript pcDNA3 magana da aka gina a cikin bincike na MDM2.
Mouse biyu minti biyu 2 (MDM2) shine E3 ubiquitin ligase wanda ke aiki a matsayin babban mai kula da ƙwayar cuta na p53.. A cikin tsarin p53 na daji, MDM2 yana ɗaure yankin ma'amalar N-terminal na p53, yi niyya don lalata proteasomal a cikin madaidaicin madaidaicin martani mara kyau, kamar yadda bayani a ciki cikakken nazari a cikin Tsarin Magunguna na Yanzu. Saboda MDM2 wuce gona da iri na iya murkushe ayyukan p53 ba tare da maye gurbin kwayoyin halitta kai tsaye ba, masu bincike akai-akai suna aika recombinant MDM2 plasmids don kimanta kama sake zagayowar tantanin halitta, apoptosis, ko ƙananan ƙwayoyin MDM2-p53 masu hanawa.
pcDNA3 Bayanin Vector Kashin baya CMV Promoter → Epitope Tag → MDM2 Saka → BGH PolyA (P53 ya danne) (Canje-canje a cikin E3) (Yankin RING) (Kwanciyar kwafin rubutu)
Plasmids kamar pcDNA3 MDM2 WT ana ƙididdige su sosai a wuraren ajiyar ilimi, ciki har da da Addgene pcDNA3 MDM2 WT database, da sake haɗawa ko gyara ta dillalai na kasuwanci kamar GenScript. pcDNA3 vector kashin baya (5.4 kb) Yana amfani da cytomegalovirus mutum (Farashin CMV) mai tallata da wuri-wuri don babban matakin magana mai shayarwa, asalin SV40 don kwafin episomal a cikin SV40 babban T-antigen yana bayyana sel masu masauki (Bayani na HEK293T), da alamar zaɓin neomycin/G418.
Kayan Aikin Gwaji 1: CMV Promoter Danniya ta Nau'in daji p53
Babban ramuwa a cikin nazarin magana na MDM2 ya ƙunshi ƙa'idodin masu talla. Yayin da mai tallata CMV a cikin pcDNA3 ana kula da shi azaman mai haɓaka mai ƙarfi, empirical studies demonstrate that CMV promoter activity is actively repressed by elevated wild-type p53 levels, kamar yadda aka nuna a cikin wani binciken da aka buga a cikin Journal of Biological Chemistry. Rasa Research Peptides Supplier
Lokacin da masu bincike suka canza pcDNA3-MDM2 zuwa sel tare da siginar p53 mara kyau, haɓaka matakan p53 suna kashe mai tallata CMV, yana haifar da rashin daidaituwa, MDM2 magana mai iyakancewa. Idan ƙungiyar bincike ta ɗauki ayyukan haɓaka akai-akai bisa ga ambaton wallafe-wallafe, canje-canje a cikin yawan furotin na MDM2 na iya zama ba daidai ba don gwada ingancin fili ko lalata bayan fassarorin maimakon kashe mai talla..
Bayanan Case na Bench (MOL Yana Canza Lab Kula da Ingancin): A cikin ingantaccen giciye na yau da kullun na ƙayyadaddun ƙayyadaddun ƙayyadaddun kayan pcDNA3 plasmid, Bidirectional Sanger sequencing a fadin mahaɗar shigar-sayar mai talla an gano bambance-bambancen nucleotide guda ɗaya da ba a taswira ba. (SNVs) a cikin yankin CMV nan da nan-fara talla. Waɗannan ƙananan ɗimbin ɗigogi sun haifar da raguwar ~ 35% a cikin ayyukan masu haɓaka tushen asali a cikin nau'ikan nau'ikan tantanin halitta idan aka kwatanta da taswirar taswirar taswirar NCBI na canonical - yana nuna dalilin da ya sa tabbatar da jerin kwayoyin halitta ya zama tilas kafin aiwatar da ƙididdigar salon salula na ƙasa..
Kayan Aikin Gwaji 2: Alamar Epitope da Canje-canjen yanki na RING-Yatsa
Don biye da recombinant MDM2, ɓangarorin kasuwanci sukan haɗa alamar N-terminal ko C-terminal epitope tags (kamar Myc, Tuta, ya da GFP). MDM2 ya dogara da yankin C-terminal RING-yatsa don ayyukan E3 ubiquitin ligase da homodimerization. Peptides masu tasowa
Idan mai siyar da kasuwanci ya canza mahadar cloning ko kuma idan an saka alamar kusa da yankin yatsa na RING ba tare da ingantaccen ingantaccen tsari ba., furotin da aka bayyana yana iya nuna raguwar ayyukan E3 ligase ko canza takamaiman takamaiman yanki. Tsarin Sanger na mahaɗaɗɗen sakawa da ƙayyadaddun ƙayyadaddun ƙayyadaddun abubuwa suna da mahimmanci don tabbatar da cewa tag ɗin bai rushe aikin nadawa yanki ba..
Hatsarin Boye na Masu Amfani da Adabi: Tsare-tsare Tsari, Tag Tsangwama, da Batch Variation
Ɗauki reagents-wanda aka ambata ba tare da tabbatarwa ba yana gabatar da manyan hanyoyin gazawar fasaha guda uku:
- Maye gurbi da ba a taswira ba: Plasmids da ke yaduwa a cikin nau'ikan ƙwayoyin cuta na iya tara maye gurbi, shigarwa, ko abubuwan transposon. Wucewa plasmid preps ba tare da jerin iyakokin shigarwa ba na iya canza ƙarfin mai talla ko gabatar da maye gurbi na shiru/rasa a cikin firam ɗin coding..
- Peptide da Reagent najasa: A cikin kira peptide (irin su MDM2-dauri helical peptides ko p53-samu tracer peptides.), masu siyar da kasuwanci na iya isar da kayan da ke ɗauke da tarkace jerin gogewa ((n-1) ko (n-2) isomers) idan tsarki bai isa ba. Abubuwan peptides na roba da ba a tsarkake ba na iya haifar da haɓakar haɓakar haɓakar ƙarya a cikin resonance na plasmon. (Farashin SPR) ko fluorescence polarization (FP) assays.
- Bambance-bambancen CoA da Rashin zaman lafiya: Takaddun Takaddun Bincike (CoAs) Masu samar da kayayyaki na iya wakiltar gwajin juzu'in tarihi maimakon takamaiman vial ɗin da aka kawo zuwa dakin gwaje-gwajen ku. Ba tare da tabbatar da gano wuri da yawa da gwada kwanciyar hankali ba, bambance-bambancen tsafta da yawa-zuwa-yawa na iya yin illa ga haɓakar ƙididdiga.
Don Tukwici: Kar a taɓa ɗauka cewa Takaddun Takaddun Bincike na Kasuwanci yana nuna yanayin halin yanzu na reagent bayan wucewa. Koyaushe gudanar da bincike na ciki da tsabta bayan an karɓa.
Ƙa'idar Tabbatar da Ingancin Matsayi na Mataki na 3 don Mahimman Bayanan Adabi
Don kare ayyukan bincike daga kayan aikin sakewa da ba a tantance ba, dakunan gwaje-gwaje ya kamata su kafa ma'auni, Gudun aiki na ingantattun orthogonal matakai uku.
Mataki 1: Binciken Layi → Mataki 2: Jeri & QC na Jiki → Mataki 3: Gudanar da Ayyuka
(CoA & INA SON Dubawa) (Singer/NGS & RP-HPLC/MS) (p53- ku & Proteasome Assays)
Mataki 1: Binciken Layi da Lutu Traceability
Kafin cirewa ko canza wani sabon vector ginawa ko peptide roba, tabbatar da cikakkun takaddun sa:
- Yi rikodin Metadata na Abu: Rubuta sunan mai siyarwa, ainihin lambar kasida, ID na clone, batch/lambar yawa, da RRID.
- Binciken Taswirar Mai siyarwa da CoA: Kwatanta taswirar plasmid da mai siyarwa ya kawo ko
Ya da Peptides Kafa Layi Mai Daskare: Don plasmids, waƙa da mai masaukin baki iri, kwayoyin zabin maida hankali, da lambar wucewa daga farkon canji.
kwayoyin zabin maida hankali, da lambar wucewa daga farkon canji.
Mataki 2: Jeri Orthogonal da Halayen Jiki
Dole ne a gudanar da tabbatarwa ta zahiri da ta gado kafin gudanar da binciken nazarin halittu:
- Rahoton da aka ƙayyade na Sanger: Yi jeri na Sanger bidirectional a duk faɗin mahaɗar saka masu talla, epitope tags, da ingantattun wuraren maye gurbi.
- Jeri Mai Gabatarwa (NGS): Don hadaddun, dogo, ko Multi-cistronic vectors, yi amfani da jerin dogon karantawa (irin su Oxford Nanopore ko PacBio) don gano ƙananan ƙididdiga masu ƙima ko kuma sake tsara ƙashin baya wanda jerin Sanger na iya ɓacewa..
- RP-HPLC da Mass Spectrometry (MS) don Peptides: Lokacin amfani da roba peptide reagents, Yi nazarin samfurin ta amfani da nazari na C18 Reverse-Phase HPLC (0.1% TFA a cikin H₂O/ACN gradient) don tabbatar da ƙuduri kololuwa (R ≥ 1.5) da tsarki (≥ 98%). Tabbatar da nauyin kwayoyin halitta ta amfani da High-Resolution Electrospray Ionization Mass Spectrometry (ESI-MS) tare da babban kuskure a ƙarƙashin 5 ppm.
Don dakunan gwaje-gwaje masu neman ingantacciyar ƙira da tabbaci, amfani a al'ada peptide kira dandamali goyan bayan m HPLC na nazari da sabis na gwaji na jama'a yana tabbatar da cewa kowane jeri da aka kawo yana fuskantar ƙayyadaddun halaye kafin amfani.
Mataki 3: Gudanarwar Tafarki Mai Aiki
Tabbatar da ilimin halitta yana tabbatar da cewa furotin da aka bayyana ko haɗakar da peptide yana aiki daidai a mahallin salon salula:
- Bayyanawa da Tabbatar da Girman Girma: Yi nazarin ɓangarorin Yammacin Turai ko bincike na rigakafi don tabbatar da cewa ginin da aka bayyana ya yi daidai da nauyin kwayoyin da aka annabta ba tare da samfuran lalata da ba zato ba tsammani..
- Sarrafa Bayanan Halittar Halitta: Lokacin kimanta abubuwan ginawa na MDM2, sun haɗa da layin p53-null cell (kamar Saos-2 ko H1299) tare da p53-wildtype Lines (kamar MCF-7 ko U2OS) don bambanta guba mai dogaro da p53 daga tasirin vector na kashe-kashe.
- Proteasome Inhibition Assays: Kula da ƙwayoyin da aka canza tare da masu hana proteasome (kamar MG132) don tabbatar da cewa ana iya ceton lalatawar p53-MDM2, kafa aikin E3 ligase aiki.
Tsarin Tabular: Lissafin Lantarki don Tabbatar da Reagent da Maimaitawa
Lissafin kimantawa na gaba yana samar da tsarin da aka tsara don
Tabbatarwa Amintaccen Kamfanin Kamfanin Kamfanin Peptide Mataki
da aka ambata vectors da na al'ada peptide reagents kafin kisa na gwaji:
| Matsayin Tabbatarwa | Siga / Gwaji | Sharuɗɗan karɓa | An Hana Kayan Aikin Farko |
|---|---|---|---|
| Mataki 1: Zuri'a | Lutu Traceability & CoA Audit | Madaidaicin adadin adadin
Liraglutide Api Manufacturer Supplier 100% jerin jerin sunayen masu tallatawa, tags, kuma saka iyakoki > Samar da isoforms na plasmid kuskure ko abubuwan da aka canza |
|
| Mataki 2: Jeri | Sanger / NGS Junction Sequencing | 100% jerin jerin sunayen masu tallatawa, tags, kuma saka iyakoki | Maye gurbi-tsara, maki maye gurbi, da gogewar haɗin gwiwa |
| Mataki 2: QC na zahiri | RP-HPLC Binciken Tsabta | Kololuwar kaifi guda ɗaya, tsarki ≥ 98%, R ≥ 1.5 | Matsalolin sharewar da aka yanke (n-1) da kuma kira gefe-samfurori |
| Mataki 2: Masa QC | Babban ƙuduri ESI-MS Peptide Synthesis | Daidaitaccen taro na monoisotopic a ciki < 5 ppm na theoretical taro | Amino acid maye gurbin da ba daidai ba ko rashin cikawa |
| Mataki 3: Aiki | Yamma Blot & Tabbatar da Magana | Madaidaicin madaurin nauyin kwayoyin halitta; babu m cleavage kayayyakin | Fatar furotin, saurin lalacewa, ko rashin magana shiru |
| Mataki 3: Hanya | Isogenic & Gudanarwar Kwayoyin Halitta | Share bambance-bambancen aiki a cikin p53-wildtype vs. p53-null Kwayoyin | Halin ƙarya na ƙwayar cuta ta vector zuwa takamaiman siginar hanya |
Kare Haɓakar Gwaji a cikin Custom Vector da Peptide R&D
Nassosin adabi suna ba da wurin farawa don zaɓin reagent, amma ba za su iya maye gurbin kula da ingancin ciki ba. Kamar yadda binciken ilimin halittu ke fuskantar babban bincike kan sake fasalin bayanai, dakunan gwaje-gwajen da ke tabbatar da kowane kayan aikin vector da peptide batch suna kare hannun jarin su, hana ɓata lokacin bincike, da kuma tabbatar da sakamakon da aka buga ya kasance da ƙarfi.
Lokacin samo kayan masarufi na musamman ko haɓaka jeri na al'ada, aiki tare da abokin aikin nazari wanda ke aiki a ciki Class 100 wuraren da bakararre mai tsabta yana tabbatar da cewa an kawar da gurɓatawar giciye da endotoxins na muhalli daga samarwa. Bugu da kari, yin amfani musamman peptide CRO mafita yana ba ƙungiyoyin bincike damar karɓar cikakkun abubuwan da aka rubuta-wanda ke tallafawa ta kowane nau'in chromatogram na HPLC, ESI-MS bakan, da ƙayyadaddun CoAs masu yawa—kafin fara tantancewar tantanin halitta.
Ta hanyar haɗa nazarin adabi masu mahimmanci tare da ƙaƙƙarfan ƙa'idar tabbatar da matakai 3, dakunan gwaje-gwaje na bincike za su iya amincewa da kayan aikin da aka ambata a cikin wallafe-wallafe yayin da suke kiyaye mutunci da sake fasalin fitowar su na kimiyya..
Matakai na gaba don R&D Ƙungiyoyi
Bukatar siffa mai zaman kanta ko haɗin peptide na al'ada mai tsafta don bututun binciken ku? Tuntuɓi ƙwararrun ƙididdiga a Canje-canje na MOL don buƙatar kimantawar fasaha, duba sigogin gwaji na nazari, ko bincika hanyoyin haɗin kai na al'ada waɗanda suka dace da buƙatun gwajin ku.
Game da Masu Bitar Kimiyya
An rubuta wannan jagorar fasaha kuma ta sake duba ta MOL Yana Canja Kwamitin Shawarar Kimiyya & Ƙungiyar Bincike- ƙungiya mai haɗaka ta manyan masana kimiyyar peptide, masana ilimin halittu, da kwararrun QC na nazari. Aiki a cikin Class 100 wuraren da bakararre mai tsabta, ƙungiyar Canje-canje ta MOL ta ƙware a ƙirar tsarin peptide na al'ada, microbial/m-lokaci kira, da ƙaƙƙarfan ingantaccen tantancewa na musamman (Farashin RP-HPLC, ESI-MS, da gwajin haihuwa) don tallafawa binciken kimiyya wanda za'a iya maimaitawa.
